Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Supriya Lifescience Limited
SUPRIYASupriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India. Address: 207/208 Udyog Bhavan, Mumbai, India, 400063
Analytics
Objectif de Cours de WallStreet
48 126.95 INRRatio C/B
33.2291Rendement du dividende
0.13 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés SUPRIYA
Analyse des dividendes SUPRIYA
Croissance des dividendes sur 5 ans
–Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
4 %Historique des dividendes SUPRIYA
Valorisation des titres SUPRIYA
financières SUPRIYA
Résultats | 2019 | Dynamique |